Related Experiment Video
Updated: Oct 10, 2025
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation
Published on: July 23, 2012
Neuroprotective effects of microRNA 124 in Parkinson's disease mice
Fubo Zhang1, Yufang Yao2, Na Miao2
1Department 4 of Neurology, Cangzhou Central Hospital, Cangzhou 061000, Hebei, China.
Background:
Recent studies have revealed the close correlation between microRNAs (miRs) and Parkinson's disease (PD). Here, we aimed to investigate the neuroprotective effect of miR-124 in a PD mouse model.
Methods:
MiR-124 expression in human plasma was detected by qRT-PCR. PD mouse model was established by stereotactic injection of 6-hydroxydopmine. Lentivirus were used to deliver and overexpress miR-124 and Axin1 into the substantia nigra. Multiple behavioral tests and oxidative stress assays were carried out to access the protective effect of miR-124 against PD. Western blot and luciferase assay were conducted to dissect the underlying molecular mechanisms.
Results:
MiR-124 expression was decreased in PD patients. Overexpression of miR-124 in PD mice could improve motor defects, ameliorate dopaminergic neurons loss, and reduce oxidative stress. Mechanistically, miR-124 targeted Axin1 directly, and then attenuated PD progression via suppressing Axin1 and activating the Wnt/β-catenin pathways in PD mice.
Conclusion:
MiR-124 is an important neuroprotective factor, which suppresses Axin1 and activates Wnt/β-catenin signaling pathways in PD mice.
Insights
MicroRNA-124 (miR-124) shows neuroprotective effects against Parkinson's disease (PD). It reduces motor deficits and neuronal loss by targeting Axin1 and activating Wnt/β-catenin pathways in PD mouse models.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRs) are increasingly recognized for their role in Parkinson's disease (PD) pathogenesis.
- Investigating specific miRs like miR-124 offers potential therapeutic targets for PD.
Purpose of the Study:
- To examine the neuroprotective potential of miR-124 in a mouse model of Parkinson's disease.
- To elucidate the molecular mechanisms underlying miR-124's effects in PD.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) for miR-124 expression analysis.
- Establishment of a 6-hydroxydopamine-induced PD mouse model.
- Lentiviral delivery for miR-124 and Axin1 overexpression in the substantia nigra.
- Behavioral tests, oxidative stress assays, Western blot, and luciferase assays to assess efficacy and mechanisms.
Main Results:
- Reduced miR-124 expression observed in PD patients.
- Overexpression of miR-124 in PD mice improved motor function and reduced dopaminergic neuron loss.
- miR-124 was found to directly target Axin1, suppressing its activity and activating Wnt/β-catenin signaling.
Conclusions:
- miR-124 acts as a significant neuroprotective factor in Parkinson's disease.
- The neuroprotective effects are mediated through the suppression of Axin1 and activation of the Wnt/β-catenin pathway.
Related Concept Videos
01:22MicroRNAs
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...